ERBB2 and gastric cancer: The results showed that the inhibition of Met reversed the Cav-1-induced cisplatin-resistance of GC cells (Figure 6A) and reduced the expression of total and phosphorylation of HER2 at Try1221/1222 site in the presence of Cav-1 (Figures 6B–D).